ENDRA Life Sciences (NDRA) EBIAT: 2016-2021
Historic EBIAT for ENDRA Life Sciences (NDRA) over the last 6 years, with Dec 2021 value amounting to -$3.1 million.
- ENDRA Life Sciences' EBIAT fell 37.94% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.2 million, marking a year-over-year increase of 4.22%. This contributed to the annual value of -$11.5 million for FY2024, which is 14.39% down from last year.
- As of Q4 2021, ENDRA Life Sciences' EBIAT stood at -$3.1 million, which was down 16.79% from -$2.7 million recorded in Q3 2021.
- In the past 5 years, ENDRA Life Sciences' EBIAT registered a high of -$741,623 during Q1 2017, and its lowest value of -$4.8 million during Q4 2019.
- In the last 3 years, ENDRA Life Sciences' EBIAT had a median value of -$3.0 million in 2020 and averaged -$3.0 million.
- In the last 5 years, ENDRA Life Sciences' EBIAT plummeted by 280.96% in 2018 and then spiked by 53.20% in 2020.
- ENDRA Life Sciences' EBIAT (Quarterly) stood at -$2.3 million in 2017, then declined by 3.09% to -$2.4 million in 2018, then crashed by 103.30% to -$4.8 million in 2019, then soared by 53.20% to -$2.3 million in 2020, then slumped by 37.94% to -$3.1 million in 2021.
- Its EBIAT stands at -$3.1 million for Q4 2021, versus -$2.7 million for Q3 2021 and -$3.2 million for Q2 2021.